News from gradalis, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 20, 2013, 08:00 ET

Gradalis Announces Appointment of Phillip B. Maples, Ph.D., as Executive Vice President and Chief Technical Officer

 Gradalis, Inc. today announced the appointment of Phillip B. Maples, Ph.D., as executive vice president and chief technical officer. Maples...

Jul 23, 2013, 08:00 ET

Gradalis Appoints Joseph M. Limber President and Chief Executive Officer

Gradalis, Inc. today announced the appointment of Joseph M. Limber as president and chief executive officer. Limber, a pharmaceutical veteran,...

May 15, 2013, 10:00 ET

FANG™ Personalized Tumor Vaccine Stimulates Immune Response and More than Doubles Time to Recurrence in Patients with Advanced Stage Ovarian Cancer

Today Gradalis, Inc. announced that FANG™, the company's tumor-based personalized cancer vaccine, elicits an immune response and delays time...

Jan 03, 2013, 08:00 ET

Gradalis, Inc. Closes $24 Million in Series B Financing to Advance Late-Stage Trials of FANG™ Personalized Cancer Vaccine

Gradalis, Inc. today announced that is has closed a $24 million Series B round of financing. Gradalis will use the funding to advance its...

Jul 11, 2012, 08:00 ET

Baylor College of Medicine and Gradalis Enter Collaboration Agreement to Utilize Gradalis' Bifunctional shRNA Platform in Translational Medicine Research

 Today Baylor College of Medicine (BCM) and Gradalis, Inc. announced the signing of a Master Collaboration Agreement focused on BCM scientists'...

Mar 01, 2012, 08:00 ET

Study Published in Molecular Therapy Shows that Immune Response to FANG™ Personalized Cancer Therapeutic Correlates with Prolonged Survival in Patients with Advanced Stage Cancer

 Today Gradalis, Inc., announced that FANG™, the company's tumor-based personalized cancer therapeutic, elicits a robust and lasting...